MARSHALL WACE, LLP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 28 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$562,600
+1.8%
54,9950.0%0.00%0.0%
Q4 2022$552,700
+1.8%
54,9950.0%0.00%0.0%
Q3 2022$543,000
+1.3%
54,9950.0%0.00%0.0%
Q2 2022$536,000
-0.4%
54,9950.0%0.00%0.0%
Q1 2022$538,000
+0.7%
54,9950.0%0.00%0.0%
Q4 2021$534,000
-1.5%
54,9950.0%0.00%
-50.0%
Q3 2021$542,00054,9950.00%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q1 2023
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 60,000$584,0000.06%
Empery Asset Management, LP 39,700$6,0000.03%
Radcliffe Capital Management, L.P. 80,001$779,0000.02%
Anson Funds Management LP 15,000$146,0000.01%
Segantii Capital Management Ltd 30,000$292,0000.01%
Arena Capital Advisors, LLC- CA 111,314$17,0000.00%
683 Capital Management, LLC 239,800$36,0000.00%
Atalaya Capital Management LP 100,000$15,0000.00%
MMCAP International Inc. SPC 159,802$24,0000.00%
MARSHALL WACE, LLP 54,995$536,0000.00%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders